| References |
|
|
book
Chanda VB (Series ed.)
(1987)
Current Protocols in Molecular Biology.
New York, NY: John Wiley & Sons.
|
|
|
Easton DF,
Ponder MA,
Huson SM and
Ponder BA
(1993)
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.
American Journal of Human Genetics
53: 305313.
|
|
|
Golub TR,
Slonim DK,
Tamayo P, et al.
(1999)
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
Science
286: 531537.
|
|
|
Guo QM,
Malek RL,
Kim S, et al.
(2000)
Identification of c-myc responsive genes using rat cDNA microarray.
Cancer Research
60: 59225928.
|
|
|
Hirano T
(1999)
Molecular basis underlying functional pleiotropy of cytokines and growth factors.
Biochemical and Biophysical Research Communications
260: 303308.
|
|
|
Hughes TR,
Marton MJ,
Jones AR, et al.
(2000)
Functional discovery via a compendium of expression profiles.
Cell
102: 109126.
|
|
|
Kistner A,
Gossen M,
Zimmermann F, et al.
(1996)
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America
93: 1093310938.
|
|
|
Shimeld SM
(1999)
Gene function, gene networks and the fate of duplicated genes.
Seminars in Cell and Developmental Biology
10: 549553.
|
|
|
Smolen P,
Baxter DA and
Byrne JH
(2000)
Mathematical modeling of gene networks.
Neuron
26: 567580.
|
|
|
Southern EM
(1975)
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
Journal of Molecular Biology
98: 503517.
|
|
|
Yu J,
Zhang L,
Hwang PM, et al.
(1999)
Identification and classification of p53-regulated genes.
Proceedings of the National Academy of Sciences of the United States of America
96: 1451714522.
|
| Further Reading |
|
|
Brown KD,
Barlow C and
Wynshaw-Boris A
(1999)
Multiple ATM-dependent pathways: an explanation for pleiotropy.
American Journal of Human Genetics
64: 4650.
|
|
|
D'Haeseleer P,
Liang S and
Somogyi R
(2000)
Genetic network inference: from co-expression clustering to reverse engineering.
Bioinformatics
16: 707726.
|
|
|
Dipple KM and
McCabe ER
(2000)
Modifier genes convert simple Mendelian disorders to complex traits.
Molecular Genetics and Metabolism
71: 4350.
|
|
|
Houlston RS and
Tomlinson IP
(1998)
Modifier genes in humans: strategies for identification.
European Journal of Human Genetics
6: 8088.
|
|
|
Huang S
(1999)
Gene expression profiling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery.
Journal of Molecular Medicine
77: 469480.
|
|
|
Livesey FJ,
Furukawa T,
Steffen MA,
Church GM and
Cepko CL
(2000)
Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx.
Current Biology
10: 301310.
|
|
|
Sanchez-Cuenca J,
Martin JC,
Pellicer A and
Simon C
(1999)
Cytokine pleiotropy and redundancy gp130 cytokines in human implantation.
Immunology Today
20: 5759.
|
|
|
book
Schena M (ed.)
(2000)
Microarray Biochip Technology.
Natick, MA: Eaton Publishing.
|
|
|
Smolen P,
Baxter DA and
Byrne JH
(2000)
Modeling transcriptional control in gene networks methods, recent results, and future directions.
Bulletin of Mathematical Biology
62: 247292.
|
|
|
Thieffry D
(1999)
From global expression data to gene networks.
Bioessays
21: 895899.
|
| Web Links |
|
|
ePath
Gene Ontology Consortium (GO) The goal of the Gene Ontology Consortium is to produce a dynamic controlled vocabulary that can be applied to all organisms, even as knowledge of gene and protein roles in cells is accumulating and changing. The three organizing principles of the Gene Ontology Consortium are molecular function (the tasks performed by individual gene products; examples are transcription factor and DNA helicase), biological process (broad biological goals, such as mitosis or purine metabolism, that are accomplished by ordered assemblies of molecular functions) and cellular component (subcellular structures, locations, and macromolecular complexes; examples include nucleus, telomere, and origin recognition complex). The GO database provided such data on numerous genes from several model species. http://www.geneontology.org/
|
|
|
ePath
neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)(NF1); LocusID: 4763. LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=4763
|
|
|
ePath
neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)(NF1); MIM number: 162200. OMIM: http://www3.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?162200
|